March 3, 2026Open Access

Evaluating Clinical Outcomes and Adverse Events: Risk Stratification of EUS-Guided Through-the-Needle Biopsy for Pancreatic Cyst in a Large Cohort

Key Points

EUS-TTNB shows notable clinical utility for revising diagnoses in patients with pancreatic cysts, enhancing treatment decisions.
The risk stratification model categorizes potential adverse events, indicating a need for careful patient selection during procedures.
Analysis of large cohort data underscores the importance of assessing risks alongside clinical outcomes in EUS-TTNB applications.
Enhanced patient selection criteria may improve safety and efficacy but necessitates further evaluations to confirm findings.

Abstract

EUS-TTNB demonstrated notable clinical utility in revising diagnoses and influencing therapeutic decisions but poses a considerable risk of AEs. By applying this risk categorization model with careful consideration and patient selection, its clinical utility may be enhanced.

Evaluating Clinical Outcomes and Adverse Events: Risk Stratification of EUS-Guided Through-the-Needle Biopsy for Pancreatic Cyst in a Large Cohort

Key Points

Abstract

Cite This Study